Skip to main content
MRAI
OTC Technology

Marpai Reports 18% Revenue Decline in Q1, Explores Strategic Alternatives Amid Financial Distress

feedReported by Wiseek News
Sentiment info
Negative
Importance info
8
Price
$0.29
Mkt Cap
$7.342M
52W Low
$0.215
52W High
$1.78
Market data snapshot near publication time

summarizeSummary

Marpai, Inc. reported first-quarter 2026 results, showing an 18% year-over-year revenue decline to $4.44 million and a net loss of $3.18 million, though diluted EPS improved to ($0.13) from ($0.21). This follows the company's 2025 10-K, which highlighted significant financial distress and a going concern warning due to a 36% revenue drop. The continued revenue decline underscores ongoing operational challenges. Critically, management announced it is exploring strategic alternatives, including investment, merger, or sale, to enhance shareholder value and support commercialization. This signals a potential major corporate event for the financially distressed company, and traders will be closely watching for updates on these strategic discussions.

At the time of this announcement, MRAI was trading at $0.29 on OTC in the Technology sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.22 to $1.78. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed MRAI - Latest Insights

MRAI
May 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
MRAI
May 15, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
MRAI
May 01, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
MRAI
Mar 25, 2026, 4:55 PM EDT
Source: Wiseek News
Importance Score:
8
MRAI
Mar 25, 2026, 4:44 PM EDT
Filing Type: 10-K
Importance Score:
9
MRAI
Mar 11, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
8
MRAI
Feb 13, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8